The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Yamada, Seiko Diane
keywords Endometrial Cancer
overview Dr. Diane Yamada specializes in the diagnosis and treatment of gynecologic cancers. She is the Section Chief for Gynecologic Oncology at the University of Chicago. Her areas of interest include: Surgery for gynecologic malignancies including ovarian, uterine and cervical cancers, as well as minimally invasive surgery Prophylactic surgery for women at high risk for the development of hereditary ovarian and endometrial cancers Management of high grade uterine cancers Intraperitoneal chemotherapy Novel clinical trials Her research focuses on new treatments and drug development for ovarian and endometrial cancer, the regulation and radiologic imaging of ovarian cancer metastasis and the unique biology of aggressive uterine cancers. She conducts clinical trials targeting ovarian cancer as well as endometrial cancer. Dr. Yamada is an editorial reviewer for a number of academic medical journals, including the American Journal of Obstetrics and Gynecology, Gynecologic Oncology, and Cancer. She is also the author or co-author of numerous peer-reviewed publications, book chapters and reviews concerning gynecologic cancers. She holds national leadership positions on the gynecologic oncology board of the American Board of Obstetrics and Gynecology and she is President-Elect II for the Society of Gynecologic Oncology.
One or more keywords matched the following items that are connected to Yamada, Seiko Diane
Item TypeName
Concept Endometrial Neoplasms
Academic Article An alpha-fetoprotein-producing hepatoid adenocarcinoma of the endometrium.
Academic Article Outcome and management of pathological stage I endometrial carcinoma patients with involvement of the lower uterine segment.
Academic Article Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies.
Academic Article Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.
Academic Article Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy.
Academic Article Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy.
Academic Article Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposure.
Academic Article Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy.
Academic Article Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma.
Academic Article Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
Academic Article Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.
Academic Article Patterns and utility of routine surveillance in high grade endometrial cancer.
Academic Article Statin Use Significantly Improves Overall Survival in High-Grade Endometrial Cancer.
Academic Article Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer.
Academic Article Immunohistochemistry for mismatch repair protein deficiency in endometrioid endometrial carcinoma yields equivalent results when performed on endometrial biopsy/curettage or hysterectomy specimens.
Academic Article Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.
Search Criteria
  • Endometrial Neoplasms